Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 12/20 | 0.45 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4218476 | 0.85 | ESR2 (0.47) | CNR2ESR2ESR1CYP3A4CYP2C9 | |
| SCHEMBL4216075 | 0.85 | CNR1 (0.40) | CNR2CNR1ESR2ESR1 | |
| SCHEMBL2720089 | 0.84 | ESR2 (0.46) | ESR2ESR1CYP3A4CYP2C9 | |
| SCHEMBL4218511 | 0.83 | CNR2 (0.38) | CNR2CNR1ESR2ESR1 | |
| SCHEMBL3441329 | 0.80 | TYR (0.53) | CNR2CNR1ESR2ESR1CYP3A4 | |
| SCHEMBL4220078 | 0.80 | CNR2 (0.38) | CNR2CNR1ESR2 | |
| SCHEMBL17589874 | 0.80 | CNR1 (0.71) | CNR2CNR1 | |
| SCHEMBL3809639 | 0.79 | CYP2C9 (0.56) | ESR2ESR1CYP3A4CYP2C9 | |
| SCHEMBL11516525 | 0.79 | TYR (0.52) | CNR2CNR1CYP3A4CYP2C9 | |
| SCHEMBL3807478 | 0.79 | CYP2C9 (0.56) | ESR2ESR1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054669-A1 | Process For Producing Epoxy Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054669-A1 | Process For Producing Epoxy Compound | RER1, AR, CYP1A1 | CNR2 644/4885CNR1 427/4885ESR2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.